| ASSET | YEAR | % RETURN |
|---|---|---|
Zepp Health (ZEPP) | 2025 | 926.92% |
DeFi Development (DFDV) | 2025 | 845.91% |
Newegg Commerce (NEGG) | 2025 | 784.13% |
Rich Sparkle Holdings Limited Ordinary Shares (ANPA) | 2025 | 727.5% |
Relmada Therapeutics (RLMD) | 2025 | 723.05% |
Palvella Therapeutics (PVLA) | 2025 | 710.42% |
Nanobiotix (NBTX) | 2025 | 572.99% |
Inhibrx Biosciences (INBX) | 2025 | 448.2% |
Invivyd (IVVD) | 2025 | 431.91% |
I-Mab (IMAB) | 2025 | 397.65% |
Better Home & Finance (BETR) | 2025 | 392.08% |
ThredUp (TDUP) | 2025 | 388.89% |
Avino Silver & Gold Mines (ASM) | 2025 | 379.12% |
Village Farms International (VFF) | 2025 | 353.61% |
Nutex Health (NUTX) | 2025 | 327.47% |
Hycroft Mining (HYMC) | 2025 | 324.78% |
Ventyx Biosciences (VTYX) | 2025 | 324.77% |
DBV Technologies (DBVT) | 2025 | 317.93% |
Monopar Therapeutics (MNPR) | 2025 | 316.18% |
Galectin Therapeutics (GALT) | 2025 | 308.4% |
IsoEnergy (ISOU) | 2025 | 303.74% |
Anywhere Real Estate (HOUS) | 2025 | 303.27% |
AXT (AXTI) | 2025 | 302.25% |
Olema Pharmaceuticals (OLMA) | 2025 | 291.39% |
So-Young International (SY) | 2025 | 288.2% |
Small-cap stocks are treated as having a market cap between $300M and $2B.
